Metabotropic glutamate receptors regulate differentiation of embryonic stem cells into GABAergic neurons

Cell Death and Differentiation

Volumn 15, Issue 4, 2008, Pages 700-707

  Sarichelou, I ^a   Cappuccio, I ^a,b   Ferranti, F ^a   Mosillo, P ^a   Ciceroni, C ^a,c   Sale, P ^a,d   Stocchi, F ^d   Battaglia, G ^c   Nicoletti, F ^a,c   Melchiorri, D ^a,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Department of Emergency Neurology   (Italy)

^c IRCCS NEUROMED   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; BETA TUBULIN; BIOLOGICAL MARKER; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 6; METABOTROPIC RECEPTOR 7; METABOTROPIC RECEPTOR 8; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; METHYL 6 (PHENYLETHYNYL)PYRIDINE; PHCCC; REAGENT; RETINOIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL MEMBRANE DEPOLARIZATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; GABAERGIC SYSTEM; IN VITRO STUDY; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINOBUTYRIC ACIDS; ANIMALS; BENZOPYRANS; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; MEMBRANE POTENTIALS; MICE; NEURONS; PHENOTYPE; PYRIDINES; RECEPTORS, METABOTROPIC GLUTAMATE; TIME FACTORS; TRETINOIN; TUBULIN;

EID: 40949147305     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402298     Document Type: Article

References (37)

1. Kinzie JM, Saugstad JA, Westbrook GL, Segerson TP. Distribution of metabotropic glutamate receptor 7 messenger RNA in the developing and adult rat brain. Neuroscience 1995; 69: 167-176.
2. Sampaio LF, Paes de Carvalho R. Developmental regulation of group III metabotropic glutamate receptors modulating adenylate cyclase activity in the avian retina. Neurochem Int 1998; 33: 367-374.
3. Di Giorgi Gerevini V, Caruso A, Cappuccio I, Ricci Vitiani L, Romeo S, Della Rocca C et al. The mGlu5 metabotropic glulamale receptor is expressed in zones of active neurogenesis of the embryonic and postnatal brain. Brain Res Dev Brain Res 2004; 150: 17-22.
4. Lujan R, Shigemoto R, Lopez Bendito G. Glutamate, and GABA receptor signalling in the developing brain. Neuroscience 2005; 130: 567-580.
5. Canudas AM, Di Giorgi Gerevini V, lacovelli L, Nano G, D'Onofrio M, Arcella A et al. PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiationof cerebellar granule cell neuroprecursors. J Neurosci 2004; 24: 10343-10352.
6. Di Giorgi Gerevini V, Melchiorri D, Battaglia G, Ricci Vitiani L, Ciceroni C, Buscati CL et al. Endogenous activation of metabotropic glutamate receptors supports the proliferation and survival of neural progenitor cells. Cell Death Differ 2005; 12: 1124-1133.
7. Luyt K, Varadi A, Halfpenny CA, Scolding NJ, Molnar E. Metabotropic glutamate receptors are expressed in adult human glial progenitor cells. Biochem Biophys Res Commun 2004; 319: 120-129.
8. Luyt K, Varadi A, Durant CF, Molnar E. Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis. J Neurochem 2006; 99: 641-656.
9. Skerry T, Genever PG. Glutamate signalling in non-neuronal tissues. Trends Pharmacol Sci 2001; 22: 174-181.
10. Arcella A, Carpinelli G, Battaglia G, D'Onofrio M, Santoro F, Ngomba RT et al. Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo. Neuro Oncol 2005; 7: 236-245.
11. lacovelli L, Arcella A, Battaglia G, Pazzaglia S, Aronica E, Spinsanti P et al. Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas. J Neurosci 2006; 26: 8388-8397.
12. Pollock PM, Cohen Solal K, Sood R, Namkoong J, Martino JJ, Koganti A et al. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet 2003; 34: 108-112.
13. Chang HJ, Yoo BC, Lim SB, Jeong SY, Kim WH, Park JG et al. Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin Cancer Res 2005; 11: 3288-3295.
14. Ango F, Prezeau L, Muller T, Tu JC, Xiao B, Worley PF et al. Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature 2001; 411: 962-965.
15. De Blasi A, Conn PJ, Pin J, Nicoletti F. Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci 2001; 22: 114-120.
16. Cappucclo I, Spinsanti P, Porcellini A, Desiderati F, De Vita T, Storto M et al. Endogenous activation of mGlu5 metabotropic glutamate receptors supports self-renewal of cultured mouse embryonic stem cells. Neuropharmacology 2005; 49 (Suppl 1): 196-205.
17. Spinsanti P, De Vita T, Di Castro S, Storto M, Formisano P, Nicoletti F et al. Endogenously activated mGlu5 receptors sustains the increase in c-Myc expression induced by leukaemia inhibitory factor in cultured mouse embryonic stem cells. J Neurochem 2006; 99: 299-307.
18. Cappuocio I, Verani R, Spinsanti P, Niccolini C, Gradini R, Costantino S et al. Context-dependent regulation of embryonic stem cell differentiation by mGlu4 metabotropic glutamate receptors. Neuropharmacology 2006; 51: 606-611.
19. Ying QL, Stavridis M, Griffiths D, Li M, Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 2003; 21: 183-186.
20. Varney MA, Lin FF, Jachec C, Rao SP, Hess SD, Johnson EC et al. Stable expression of human NMDA receptors in cultured mammalian cells. Methods Mol Biol 1999; 120: 43-59.
21. Pagano A, Ruegg D, Litschig S, Stoehr N, Stierlin C, Heinrich M et al The non-competitive antagonists 2-methyl-6(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b] chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glulamate receptor. J Biol Chem 2000; 275 33750-33758.
22. Guan K, Chang H, Rolletschek A, Wobus AM. Embryonic stem cell-derived neurogenesis. Retinoic acid induction and linear selection of neuronal cells. Cell Tissue Res 2001; 305: 171-176.
23. Bibel M, Richter J, Schrenk K, Tucker KL, Staiger V, Korte M et al Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat Neurosci 2004; 7: 1003-1009.
24. Tanabe Y, Nomura A, Masu M, Shigemoto R, Mizuno N, Nakanishi S. Signil transduction, pharmacological properties and expression patterns of two rat metabotropic glutarnate receptors, mGluR3 and mGluR4. J Neurosci 1993; 13: 1372-1378.
25. Bjorklund A, Lindvall O. Cell replacement therapies for central nervous system disorders. Nature Neurosci 2000; 3: 537-544.
26. Maj M, Bruno V. Dragic Z, Yamamoto R, Battaglia G, Inderbitzin W et al. PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection. Neuropharmacology 2003; 45: 895-906.
27. Yu M, Tueckmantel W, Wang X, Zhu A, Kozikowski AP, Brownell AL. Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine: Synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors. Nucl Med Biol 2005; 32: 631-640.
28. Storto M, Capobianco L, Battaglia G, Molinaro G, Gradini R, Riozzi B et al. Insuilin secretion is controlled by mGlu5 metabotropic glutamate receptors. Mol Pharmacol 2006; 69: 1234-1241.
29. Battaglia G, Busceti CL, Molinaro G, Biagioni F, Traficante A, Nicoletti F et al. Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methy-4-phenyl-1,2,3,6-tetrahy-dropyridine. J Neurosci 2006; 26: 7222-7229.
30. Bruno V, Ksiazek I, Battaglia G, Lukic S, Leonhardt T, Sauer D et al Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective. Neuropharmacology 2000; 39: 2223-2230.
31. Battaglia G, Fornai F, Busceti CL, Aloisi G, Cerrito F, De Blasi A et al. Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity. J Neurosci 2002; 22: 2135-2141.
32. Popoli P, Pintor A, Tebano MT, Frank C, Pepponi R, Nazzicone V et al Neuroprotective effects of the mGluR5 antagonist MPEP towards quinolinic acid-induced striatal toxicity: Involvement of pre- and post-synapfic mechanisms and lack of direct NMDA blocking activity. J Neurochem 2004; 89: 1479-1489.
33. Schiefer J, Sprunken A, Puls C, Luesse HG,Milkereit A, Milkereit E et al. The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease. Brain Res 2004; 1019: 246-254.
34. Bain G, Ray WJ, Yao M, Gottlieb DI, Retinoic acid promotes neural and represses mesodermal gene expression in mouse embryonic stem cells in culture. Biochem Biophys Res Commun 1996; 223: 691-694.
35. Ting QL, Smith AG. Defined conditions for neural commitment and differentiation. In: Wassarman PM, Keller GM (eds). New York Academic Press Methods in Enzymology. 2003; 365, pp 327-345.
36. Okada Y, Shimazaki T, Sobue G, Okano H. Retinoic acid concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells. Dev Biol 2004; 275: 124-142.
37. D'Onofrio M, Arcella A, Bruno V, Ngomba T, Battaglia G, Lombari V et al. Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells. J Neurochem 2003; 84: 1288-1295.